PEDIATRIC SOLID TUMOR
Clinical trials for PEDIATRIC SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new PEDIATRIC SOLID TUMOR trials appear
Sign up with your email to follow new studies for PEDIATRIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes pill trial offers new hope for kids with tough cancers
Disease control Recruiting nowThis early-stage study is testing whether adding the diabetes drug dapagliflozin to standard cancer treatment is safe for children and young adults with recurrent brain tumors or solid tumors that have come back or resisted treatment. The main goal is to check for side effects, b…
Matched conditions: PEDIATRIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug aims to halt Cancer's deadly spread in first human test
Disease control Recruiting nowThis is the first-ever study in people of an experimental drug called metarrestin. The main goals are to find a safe dose and see if it can shrink tumors. It is for adults and teenagers (12+) with advanced solid tumors that have spread and have not been cured by standard treatmen…
Matched conditions: PEDIATRIC SOLID TUMOR
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for kids with tough cancers: first trial of a novel cell therapy
Disease control Recruiting nowThis is a first-in-human study testing a new type of personalized cell therapy for children and young adults (up to age 21) whose solid tumors have come back or haven't responded to standard treatments. Doctors will collect a patient's own immune cells (T cells), genetically modi…
Matched conditions: PEDIATRIC SOLID TUMOR
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New hope for kids with tough cancers: Four-Drug combo trial opens
Disease control Recruiting nowThis study is testing a new combination of four medicines for children and young adults (under 30) whose solid tumors have come back or haven't responded to standard treatments. The first part checks if the drug mix is safe and finds the right dose. The second part sees how well …
Matched conditions: PEDIATRIC SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Massive 10,000-Person hunt for clues to beat rare cancers
Knowledge-focused Recruiting nowThis study aims to learn more about rare cancers by collecting health information and biological samples from people who have them or are at risk. Researchers will follow 10,000 participants over time to understand how these rare tumors develop and behave. The goal is to use this…
Matched conditions: PEDIATRIC SOLID TUMOR
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC